BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23826116)

  • 1. Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis.
    Liu Y; Li C; Chen P; Li X; Li M; Guo H; Li J; Chu R; Wang H
    PLoS One; 2013; 8(6):e66716. PubMed ID: 23826116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis.
    Song GG; Lee YH
    Immunol Invest; 2013; 42(7):661-72. PubMed ID: 24004063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: A meta-analysis.
    Mun MJ; Kim TH; Hwang JY; Jang WC
    Maturitas; 2015 Jun; 81(2):256-65. PubMed ID: 25882760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VDR gene FokI polymorphism and ovarian cancer risk.
    Xu H; Li S; Qiu JQ; Gao XL; Zhang P; Yang YX
    Tumour Biol; 2013 Dec; 34(6):3309-16. PubMed ID: 24078452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer.
    Beysel S; Eyerci N; Pinarli FA; Apaydin M; Kizilgul M; Caliskan M; Ozcelik O; Kan S; Cakal E
    Tumour Biol; 2018 Nov; 40(11):1010428318811766. PubMed ID: 30486759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor gene FokI, TaqI, BsmI, and ApaI polymorphisms and susceptibility to pulmonary tuberculosis: a meta-analysis.
    Lee YH; Song GG
    Genet Mol Res; 2015 Aug; 14(3):9118-29. PubMed ID: 26345844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.
    Coşkun S; Şimşek Ş; Camkurt MA; Çim A; Çelik SB
    Gene; 2016 Aug; 588(2):109-14. PubMed ID: 27155524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D receptor gene polymorphisms and multiple myeloma: a meta-analysis.
    Lyu C; Yin X; Li Z; Wang T; Xu R
    Clin Exp Med; 2024 Jun; 24(1):118. PubMed ID: 38833040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor gene polymorphisms and osteoarthritis: a meta-analysis.
    Li HM; Liu Y; Zhang RJ; Ding JY; Shen CL
    Rheumatology (Oxford); 2021 Feb; 60(2):538-548. PubMed ID: 33147632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VDR gene FokI polymorphism is associated with gestational diabetes mellitus in Turkish women.
    Apaydın M; Beysel S; Eyerci N; Pinarli FA; Ulubay M; Kizilgul M; Ozdemir O; Caliskan M; Cakal E
    BMC Med Genet; 2019 May; 20(1):82. PubMed ID: 31096931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApaI, BsmI, FokI, and TaqI Polymorphisms in the Vitamin D Receptor Gene and Parkinson's Disease.
    Niu MY; Wang L; Xie AM
    Chin Med J (Engl); 2015 Jul; 128(13):1809-14. PubMed ID: 26112724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor TaqI, BsmI and ApaI polymorphisms and osteoarthritis susceptibility: a meta-analysis.
    Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
    Joint Bone Spine; 2009 Mar; 76(2):156-61. PubMed ID: 19073371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.
    Xu Y; He B; Pan Y; Deng Q; Sun H; Li R; Gao T; Song G; Wang S
    Tumour Biol; 2014 May; 35(5):4153-69. PubMed ID: 24408013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis.
    Zintzaras E; Rodopoulou P; Koukoulis GN
    Dis Markers; 2006; 22(5-6):317-26. PubMed ID: 17264402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between vitamin D receptor polymorphisms and susceptibility to Parkinson's disease: An updated meta-analysis.
    Gao J; Teng J; Liu Z; Cai M; Xie A
    Neurosci Lett; 2020 Feb; 720():134778. PubMed ID: 31978499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between vitamin D receptor polymorphisms and vitiligo susceptibility: An updated meta-analysis.
    Lee YH; Song GG
    J Cosmet Dermatol; 2023 Mar; 22(3):969-979. PubMed ID: 36254395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of vitamin D receptor polymorphisms with metabolic syndrome-related components: A cross-sectional study.
    Jin T; Lu W; Gong X; Zhou J; Wu F
    J Clin Lab Anal; 2021 Jul; 35(7):e23829. PubMed ID: 34008880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of vitamin D receptor BsmI, TaqI, FokI, and ApaI polymorphisms with susceptibility of chronic periodontitis: A systematic review and meta-analysis based on 38 case -control studies.
    Mashhadiabbas F; Neamatzadeh H; Nasiri R; Foroughi E; Farahnak S; Piroozmand P; Mazaheri M; Zare-Shehneh M
    Dent Res J (Isfahan); 2018; 15(3):155-165. PubMed ID: 29922333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and the susceptibility to breast cancer: a meta-analysis.
    Lee YH; Song GG
    Neoplasma; 2014; 61(5):607-16. PubMed ID: 25244980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.